Literature DB >> 15935609

Inflammatory mediators and eosinophilia in atopic and non-atopic patients with nasal polyposis.

M C Scavuzzo1, B Fattori, R Ruffoli, V Rocchi, A Carpi, R Berni, M A Giambelluca, F Giannessi.   

Abstract

Nasal polyps are characterized by eosinophilic infiltration and presence of inflammatory mediators, such as total IgE, eosinophil cationic protein (ECP) and cytokines. The role of atopy in nasal polyp pathogenesis is still unclear. Therefore, we evaluated serum IgE levels, nasal mucus concentrations of ECP and cytokines and the number of infiltrating eosinophils in nasal tissue of polyps from atopic and non-atopic patients. Samples were obtained from a randomized population of 31 patients with nasal polyposis having endonasal sinus surgery and of 13 control subjects undergone corrective surgery of the nasal septum. On the basis of medical history of allergy, positive skin-prick tests and total IgE levels, patients with polyposis were divided in atopic (n = 13) and non-atopic (n = 18) patients. We determined levels of IgE in blood, ECP and cytokines (IL-4, IL-6, IL-8, IFN-gamma and IL-2) in nasal mucus, and number of infiltrating eosinophils in nasal tissue. The concentrations of total IgE, ECP, IL-4 and IL-8 and eosinophilia were significantly higher in all patients with nasal polyps compared with controls. Inside, all patients with nasal polyposis showed lower levels of IL-6, IFN-gamma and IL-2 compared with controls. The atopic patients showed significant differences when compared with non-atopic patients for the higher concentrations of total IgE (698.80+/-322.24 vs. 279.63+/-234.11; P < 0.0001) and IL-8 (1437.2 pg/ml+/-1250.7 vs. 605.5 pg/ml+/-481.1; P < 0.015). These findings suggest that inflammation still remains the major factor in the etiology of nasal polyposis and show different levels of inflammatory mediators into atopic and non-atopic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935609     DOI: 10.1016/j.biopha.2004.11.010

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Mucus T helper 2 biomarkers predict chronic rhinosinusitis disease severity and prior surgical intervention.

Authors:  Justin H Turner; Ping Li; Rakesh K Chandra
Journal:  Int Forum Allergy Rhinol       Date:  2018-06-08       Impact factor: 3.858

2.  Effects of IL-17 on expression of GRO-α and IL-8 in fibroblasts from nasal polyps.

Authors:  Yong-Zhi Niu; Guo-Qing Gong; Shan Chen; Jian-Jun Chen; Wei-Jia Kong; Yan-Jun Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

3.  Clinical significance of eosinophilic cationic protein levels in nasal secretions of patients with nasal polyposis.

Authors:  Dong-Il Sun; Young-Hoon Joo; Hyeon-Jin Auo; Jun-Myung Kang
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-26       Impact factor: 2.503

4.  Association of IL1β and IL4 gene polymorphisms with nasal polyps in a Polish population.

Authors:  Malgorzata Mrowicka; Hanna Zielinska-Blizniewska; Jaroslaw Milonski; Ireneusz Majsterek; Jurek Olszewski
Journal:  Mol Biol Rep       Date:  2014-03-26       Impact factor: 2.316

5.  Distinct inflammatory profiles in atopic and nonatopic patients with chronic rhinosinustis accompanied by nasal polyps in Western china.

Authors:  Luo Ba; Jintao Du; Feng Liu; Fenglin Yang; Miaomiao Han; Sixi Liu; Ping Lin; Huabin Li
Journal:  Allergy Asthma Immunol Res       Date:  2015-07       Impact factor: 5.764

6.  Deprived TLR9 expression in apparently healthy nasal mucosa might trigger polyp-growth in chronic rhinosinusitis patients.

Authors:  Lotta Tengroth; Julia Arebro; Susanna Kumlien Georén; Ola Winqvist; Lars-Olaf Cardell
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

Review 7.  Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities.

Authors:  Michael Koennecke; Ludger Klimek; Joaquim Mullol; Philippe Gevaert; Barbara Wollenberg
Journal:  Allergo J Int       Date:  2018-01-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.